Navigation Links
Royalty Pharma Acceptances Announcement
Date:6/6/2013

NEW YORK, June 7, 2013 /PRNewswire/ -- In accordance with Rule 17.1 and Rule 2.9 of the Irish Takeover Rules and Rule 14e-1 of the US Exchange Act, Echo Pharma Acquisition Limited ("Royalty Pharma") today announced acceptance levels of its Increased Offer for Elan Corporation (NYSE: ELN).

Background

On 2 May 2013, Echo Pharma Acquisition Limited ("Royalty Pharma") made an offer for the entire of the issued and to be issued share capital of Elan Corporation, plc ("Elan") (the "Original Offer").

On 20 May 2013, Royalty Pharma announced the terms of a revision to the Original Offer (the "Increased Offer"). The Increased Offer was made on 23 May 2013 and is an all cash offer of US$12.50 per Elan Share (including each Elan Share represented by an Elan ADS). The full terms of, and conditions to, the Increased Offer and the procedure for acceptance are set out in the revised offer document despatched by Royalty Pharma on 23 May 2013 (the "Revised Offer Document"). The initial closing date for the Increased Offer, as set out in the Revised Offer Document, was 1:00 p.m. (Irish time) / 8:00 a.m. (New York City time) on 6 June 2013 (unless extended).

On 6 June 2013, Royalty Pharma announced that the closing date for the Increased Offer was extended until 1:00 p.m. (Irish time) / 8:00 a.m. (New York City time) on Friday, 21 June 2013 and will remain open for acceptance until that time (unless further extended).

A reference in this announcement to the "Offer" means the Original Offer (including where the context so requires, any subsequent revision, variation, extension or renewal of the Original Offer, including in connection with the Increased Offer). Capitalised terms used but not defined in this announcement shall have the meaning given to them in the Revised Offer Document.

Royalty Pharma is making this announcement in accordance with Rule 1
'/>"/>

SOURCE Royalty Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Royalty Pharma Responds To Elans Tysabri Valuation
2. Royalty Pharma Response To Elans "Categorical View On Value"
3. Royalty Pharma Recommends Elan Shareholders vote "NO" on each of the Elan Resolutions at the Elan extraordinary general meeting
4. Royalty Pharma Issues Investor Presentation Highlighting The Strategic And Financial Advantages Of Its Offer To Acquire Elan For $12.50 Per Share In Cash
5. Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements
6. Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share
7. Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
8. Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals
9. PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger
10. Royalty Rates for Pharmaceuticals & Biotechnology: Real-Deal Information for Hundreds of Transactions
11. PDL BioPharma Provides First Quarter 2013 Royalty Revenue Guidance of $92 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... Axxess , an industry leader in ... vendor accredited by the American Nursing Credentialing Center – ... agencies select the right revenue cycle management (RCM) system ... business. Research by American Health Information Management ... a decrease in productivity of 54.4 - 69 percent ...
(Date:6/29/2015)... June 29, 2015 The Parenteral Drug Association ... Jersey Board of Professional Engineers and Land ... courses to professional engineers for continuing professional competency (CPC) ... the value and quality of PDA,s professional education offerings," ... courses and hands-on professional training at the Training and ...
(Date:6/29/2015)... June 29, 2015  Pressure BioSciences, Inc. (OTCQB: ... the development and sale of broadly enabling, pressure ... worldwide life sciences industry, today announced that Tiannan ... Systems Biology, ETH Zurich, presented data on an ... of prostate cancer tissue biopsy samples at the ...
Breaking Medicine Technology:Axxess Releases eGuide for Home Health Agencies, Revenue Cycle Management: What You Must Do Now - to Succeed! 2Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 2Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 3Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 4
... Association rapid access journal report:Study highlights:-- Implantable ... of death by 30 percent in patients ... applied to patients 75 years and older ... have focused on younger, healthier patients.DALLAS, Jan. ...
... Corporation (Nasdaq: MNKD ) today announced ... its commercial inhaler to the version of the device ... MannKind,s ultra rapid acting insulin that recently completed Phase ... Clinical and Commercial Scale Inhalers Study 138 compared the ...
Cached Medicine Technology:Implantable Defibrillators Lower Risk of Death in Older Heart Patients 2Implantable Defibrillators Lower Risk of Death in Older Heart Patients 3MannKind Reports Successful Completion of Device Bioequivalence Trial 2MannKind Reports Successful Completion of Device Bioequivalence Trial 3
(Date:6/29/2015)... ... 29, 2015 , ... New research released today at the ... of U.S. state and local governments have implemented Next Generation 9-1-1 (NG9-1-1) systems, ... , “Mobile phones have surpassed land lines as the primary mode for ...
(Date:6/29/2015)... ... 2015 , ... Celebrities have many skincare secrets, and skin expert, Holly CaSaroll ... and beyond. People don’t have to be famous to have fabulous skin. CaSaroll ... even skin tone, avoid breakouts, and take skin health and wellness to a new ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... and behavior, is a popular focus for corporate training seminars. As many as ... practices, improve training, foster teamwork, and increase productivity. , With the demand ...
(Date:6/29/2015)... ... June 29, 2015 , ... National ... responsible and legal access to Health Canada's medical cannabis program, today officially opened ... on how Health Canada's medical marijuana system works. Members are connected with a ...
(Date:6/29/2015)... ... June 29, 2015 , ... BaliniSports has been announced as an official sponsor ... later this year. This year’s contestants will be wearing pieces from the BaliniSports collection ... competition will go on to represent the state in the Miss Teen USA competition. ...
Breaking Medicine News(10 mins):Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 2Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 3Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 4Health News:Skin Guru Shares Celebrity FACE Secrets For Summer-Proofing The Skin 2Health News:Skin Guru Shares Celebrity FACE Secrets For Summer-Proofing The Skin 3Health News:As Demand for DISC Trainers Rises, PeopleKeys Offers Support with “THE DISC FACTOR—Train the Trainer” Webinar 2Health News:National Access Cannabis Opens Flagship Ottawa Care Centre 2Health News:National Access Cannabis Opens Flagship Ottawa Care Centre 3Health News:BaliniSports Announced as Sponsor of the Miss Teen Nevada 2016 Competition 2
... In either an,inadvertent omission or a betrayal ... Nunez lacks any mention of the tax,credits he ... that is otherwise unaffordable, said the Foundation for ... concern that though the funding source for,expansion of ...
... CGH with Illumina,s BeadStudio Software -, ... announced,today that it joined Illumina Connect, a ... analysis of microarray data. After,collaborating with Illumina, ... customers using both Illumina,s BeadStudio software,to seamlessly ...
... Neuralstem Inc.,(Amex: CUR ) today reported financial ... 2007. (Logo: http://www.newscom.com/cgi-bin/prnh/20061221/DCTH007LOGO ) For the ... loss of,$1,422,020, or $(0.05) per share, compared to $211,088, ... loss attributable to common,stockholders for the first nine months ...
... diabetes werent enough to handle, a new study shows that ... least one other major chronic medical condition and that ... diabetes. , The sheer number, and the severity, of ... their diabetes. The type of co-existing condition also matters, as ...
... number of lymph nodes after colon cancer surgery, a ... for hospitals, is not associated with length of patient ... issue of JAMA. , Several studies have suggested ... of nodes are examined after colectomy for colon cancer ...
... may not be as useful as thought, researchers say , , ... questioning the conventional wisdom of checking on the health of ... checks have been thought to be a good indicator of ... doubt. , "What we are finding is that focusing on ...
Cached Medicine News:Health News:Nunez Health Reform Bill Establishes Mandatory Purchase Without Linking to Subsidies for Middle Class and Poor 2Health News:Nunez Health Reform Bill Establishes Mandatory Purchase Without Linking to Subsidies for Middle Class and Poor 3Health News:Nunez Health Reform Bill Establishes Mandatory Purchase Without Linking to Subsidies for Middle Class and Poor 4Health News:Nunez Health Reform Bill Establishes Mandatory Purchase Without Linking to Subsidies for Middle Class and Poor 5Health News:Nunez Health Reform Bill Establishes Mandatory Purchase Without Linking to Subsidies for Middle Class and Poor 6Health News:Nunez Health Reform Bill Establishes Mandatory Purchase Without Linking to Subsidies for Middle Class and Poor 7Health News:BioDiscovery Joins Illumina Connect Bioinformatics Program 2Health News:Neuralstem Inc. Reports 2007 Third Quarter Financial Results and Events 2Health News:Neuralstem Inc. Reports 2007 Third Quarter Financial Results and Events 3Health News:Neuralstem Inc. Reports 2007 Third Quarter Financial Results and Events 4Health News:Neuralstem Inc. Reports 2007 Third Quarter Financial Results and Events 5Health News:Neuralstem Inc. Reports 2007 Third Quarter Financial Results and Events 6Health News:Neuralstem Inc. Reports 2007 Third Quarter Financial Results and Events 7Health News:Diabetes dilemma: older people with diabetes face a heavy burden from co-existing health conditions 2Health News:Diabetes dilemma: older people with diabetes face a heavy burden from co-existing health conditions 3Health News:Diabetes dilemma: older people with diabetes face a heavy burden from co-existing health conditions 4Health News:Hospital quality indicator may not be linked to patient survival after colon cancer surgery 2Health News:Hospital quality indicator may not be linked to patient survival after colon cancer surgery 3Health News:Study Challenges Colon Cancer Surgery Follow-Up 2Health News:Study Challenges Colon Cancer Surgery Follow-Up 3
Solid lower plate with outside width 15 mm. Open serrated upper plate with inside dimensions 9 x 12 mm. Serrated handle with locking thumb screw and polished finish....
Narrow smooth jaws. Serrated handle with polished finish....
14 mm oval solid lower plate and straight 9 mm serrated upper jaw. Locking thumb screw and serrated handle with polished finish....
Round solid 10 mm wide lower plate. Open upper plate with inside diameter 8 mm. Serrated handle with locking thumb screw and polished finish. Most popular size or model....
Medicine Products: